CD4 and peanut allergic reaction: We aimed to design peptides based on the most reliably recognized CD4+ T cell epitopes of major peanut allergens for a T cell-targeted immunotherapy for peanut allergy as a safe (non-IgE reactive) and effective alternative to whole allergens.